ArticleFrontiers in pharmacology2025
Impact of different doses of rivaroxaban on clinical outcomes in elderly patients with non-valvular atrial fibrillation: a real-world study.
Juan Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.